TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 156 filers reported holding TURNING POINT THERAPEUTICS I in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $557,000 | +11.0% | 7,400 | -60.4% | 0.00% | 0.0% |
| Q1 2022 | $502,000 | -95.5% | 18,700 | -86.9% | 0.00% | -92.9% |
| Q2 2021 | $11,133,000 | -0.5% | 142,700 | +20.6% | 0.01% | 0.0% |
| Q1 2021 | $11,190,000 | +169.3% | 118,300 | +246.9% | 0.01% | +180.0% |
| Q4 2020 | $4,155,000 | -51.0% | 34,100 | -64.9% | 0.01% | -37.5% |
| Q3 2020 | $8,483,000 | -13.1% | 97,100 | -35.8% | 0.01% | 0.0% |
| Q2 2020 | $9,766,000 | +124.5% | 151,200 | +55.2% | 0.01% | +100.0% |
| Q1 2020 | $4,350,000 | – | 97,394 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,392,297 | $291,501,000 | 6.94% |
| Burrage Capital Management LLC | 72,484 | $8,832,000 | 6.73% |
| MPM BioImpact LLC | 617,372 | $75,226,000 | 6.50% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 113,541 | $13,816,000 | 3.77% |
| Orbimed Advisors | 2,745,327 | $334,518,000 | 2.93% |
| SECTORAL ASSET MANAGEMENT INC | 257,379 | $31,362,000 | 2.21% |
| Parkman Healthcare Partners LLC | 59,377 | $7,235,000 | 1.85% |
| Nicholas Investment Partners, LP | 183,676 | $22,381,000 | 1.73% |
| EMERALD ADVISERS, LLC | 357,038 | $43,505,000 | 1.44% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 336,173 | $40,963,000 | 1.42% |